Cargando…
Identification of circulating tumor DNA using a targeted 545-gene next generation sequencing panel in patients with gastric cancer
Gastric cancer (GC) is characterized by unique genetic aberrations. Some of these mutations may be used to predict tumor prognosis or to guide patient therapy. Cell-free circulating tumor DNA (ctDNA) has been considered a promising alternative to biopsy to identify genome aberrations. However, no st...
Autores principales: | Lan, Jing, Lu, Yaping, Guan, Yanfang, Chang, Lianpeng, Yu, Zhengyuan, Qian, Haixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039113/ https://www.ncbi.nlm.nih.gov/pubmed/32194723 http://dx.doi.org/10.3892/ol.2020.11305 |
Ejemplares similares
-
Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer
por: Deng, Jingyu, et al.
Publicado: (2015) -
Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2020) -
Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022) -
Evaluation of a Targeted Next-Generation Sequencing Panel for the Non-Invasive Detection of Variants in Circulating DNA of Colorectal Cancer
por: Rodríguez-Casanova, Aitor, et al.
Publicado: (2021) -
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
por: Zhang, Yongliang, et al.
Publicado: (2021)